Alector, Inc.
Status: Publicly traded
Direct answer
Alector, Inc. is publicly traded on NASDAQ under the ticker ALEC.
Alector, Inc. operates as a clinical-stage biopharmaceutical company, which engages in pioneering of immuno-neurology. It develops portfolio of innate immune system programs, designed to functionally repair genetic mutations and enable the rejuvenated immune cells to counteract emerging brain pathologies. Its treatment targets immune dysfunction as a root cause of multiple pathologies that are drivers of...
Can you invest in Alector, Inc.?
Yes. Alector, Inc. trades publicly on NASDAQ as ALEC.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Alector, Inc.
Detailed equity research is provided by MarketSnap.